ImmuneSpec
PrivateLast Round
Seed
Mar 24, 2023
Total Funding Raised
$1.3M
Company Overview
ImmuneSpec operates in Healthcare & Life Sciences and is based in Niel. Its latest recorded funding round was a Seed round in March 2023.
ImmuneSpec is a biotechnology company that provides high-sensitivity immunopeptidomics analysis services for the development of vaccines, immunotherapeutics, and personalized medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuneSpec Comparables
Compare ImmuneSpec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pure MHC, LLC | 78% | |
| Bruker | 76% | |
| MS Bioworks | 74% |
For institutional investors. Book with your work email.
ImmuneSpec Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ImmuneSpec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HERAN Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2025
Grew 33% QoQ from 9 to 12 employees.
- Mar 24, 2023
$1.3M round led by HERAN Partners
For institutional investors. Book with your work email.
ImmuneSpec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ImmuneSpec's valuation, stock price, and market status.
Is ImmuneSpec a public or private company?
ImmuneSpec is a private company.
What is the current stock price of ImmuneSpec?
ImmuneSpec is a private company, so its shares have no public market price. Caplight tracks ImmuneSpec's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ImmuneSpec worth (valuation)?
Valuation information for ImmuneSpec is not publicly available.
Can I buy ImmuneSpec stock?
ImmuneSpec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ImmuneSpec's last funding round?
ImmuneSpec's most recent funding round was Seed on March 24, 2023.
Who are the main investors in ImmuneSpec?
Key investors in ImmuneSpec include HERAN Partners.
Will ImmuneSpec IPO soon?
No public IPO plans have been announced for ImmuneSpec.
How can I track ImmuneSpec secondary market activity?
Caplight tracks bids, offers, and trades in ImmuneSpec's shares on secondary markets.